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Abstract
Background: Although published results are inconsistent, it has been suggested that tattooing and piercing are risk factors
for HBV and HCV infections. To examine whether tattooing and piercing do indeed increase the risk of infection, we
conducted a study among people with multiple tattoos and/or piercings in the Netherlands who acquired their tattoos and
piercings in the Netherlands and/or abroad.
Methods: Tattoo artists, piercers, and people with multiple tattoos and/or piercings were recruited at tattoo conventions,
shops (N=182), and a biannual survey at our STI-outpatient clinic (N=252) in Amsterdam. Participants were interviewed
and tested for anti-HBc and anti-HCV. Determinants of HBV and HCV infections were analysed using logistic regression
analysis.
Results: The median number of tattoos and piercings was 5 (IQR 2–10) and 2 (IQR 2–4), respectively. Almost 40% acquired
their tattoo of piercing abroad. In total, 18/434 (4.2%, 95%CI: 2.64%–6.46%) participants were anti-HBc positive and 1 was
anti-HCV positive (0.2%, 95%CI: 0.01%–1.29%). Being anti-HBc positive was independently associated with older age (OR
1.68, 95%CI: 1.03–2.75 per 10 years older) and being born in an HBV-endemic country (OR 7.39, 95%CI: 2.77–19.7). Tattoo-
and/or piercing-related variables, like having a tattoo or piercing in an HBV endemic country, surface percentage tattooed,
number of tattoos and piercings etc., were not associated with either HBV or HCV.
Conclusions: We found no evidence for an increased HBV/HCV seroprevalence among persons with multiple tattoos and/or
piercings, which might be due to the introduction of hygiene guidelines for tattoo and piercing shops in combination with
the low observed prevalence of HBV/HCV in the general population. Tattoos and/or piercings, therefore, should not be
considered risk factors for HBV/HCV in the Dutch population. These findings imply the importance of implementation of
hygiene guidelines in other countries.
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Introduction
Hepatitis B virus (HBV) and hepatitis C virus (HCV) can both
become chronic infections, causing liver cirrhosis, hepatocellular
carcinoma, and eventually death. HBV is transmitted by sexual
contact and by blood contact, whereas HCV is primarily a blood-
borne infection [1,2].
Tattooing and piercing have been performed for thousands of
years and have been notably popular in recent years. In the
Netherlands, an estimated 6% of the general population have at
least 1 tattoo and approximately 3% have 1 or more body
piercings, excluding regular ear piercings [3].
It has been suggested that people with multiple tattoos and/or
piercings are at increased risk for HBV and HCV. However, study
results are inconsistent [4]. The association between HBV and
tattoos was chiefly found in the 1980s and early 1990s [5–7], in
more recent literature, rarely is an association found [8,9]. The
association between HCV and tattoos has been inconsistent
throughout time [4,10–13], but when there have been associa-
tions, they have been found primarily among HCV high-risk
populations [4]. Acari et al. reported in their review that none of
the studies found an association between body piercing and HCV
infection [4].
Tattoo artists and piercers are at possibly even higher risk than
their clients for HBV and HCV. They usually have multiple
tattoos and piercings themselves, and also because of the lack of
sterilization procedures in the past in combination with needle-
stick accidents. During an investigation of an HBV outbreak in
Amsterdam in 1982, which was traced back to a HBV-infected
tattoo artist, many other practices surfaced that likely put clients at
risk for infection, such as reusing needles and insufficient or lack of
sterilization procedures. As a result of this incident, the Dutch
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the Pubic Health Service of Amsterdam (PHSA), the first set of
guidelines for tattoo shops in Amsterdam. More elaborate
guidelines were established in 1987 [14]. In 1990, these guidelines
were expanded to include piercing and permanent make-up
studios.
To the best of our knowledge, no study on HBV and HCV has
been performed exclusively among people with multiple tattoos
and piercings including tattoo artists. We examined the HBV and
HCV prevalence in this population and its relationship with tattoo
and piercings practices in a city where guidelines for hygienic
practices were introduced two decades ago.
Methods
Ethics statement
The medical ethics committee of the Academic Medical Centre
(MEC AMC) approved the current study.
Study population and study procedures
Dutch- or English-speaking tattoo artists and/or piercers living
in the Netherlands and people with multiple tattoos and/or
piercings (not those with only regular ear piercings) were
approached to participate in this study. Participants were recruited
at three sites: tattoo conventions in June 2007 and June 2008 in
Amsterdam (N=130); at tattoo and/or piercing shops in
Amsterdam (2008–2010) (N=64); and during two waves of a
biannual HIV- and HCV-survey at the sexually transmitted
infection (STI) outpatient clinic of Amsterdam in November 2008
and April 2009 (N=361) [15]. Since recent data have shown that
HCV is emerging as an STI among HIV-infected men who have
sex with men (MSM) and prevalent in this group [15], all MSM
(N=83) were excluded in this analysis. In addition, to avoid
possible confounding, all participants with a history of being an
injecting drug user (IDU)(N=3) were excluded. Participants
lacking an HBV core antigen (anti-HBc) or anti-HCV test result
(N=35) were also excluded, leaving 434 participants as our study
population.
Recruitment at tattoo sites. After we obtained written
informed consent, the participants ($18 years) were interviewed
about sociodemographics, risk factors for blood-borne diseases,
and about tattoo- and/or piercing-related characteristics; blood
was collected for HBV/HCV testing. Subjects were included at
the site of the convention by convenience sampling.
Tattoo and/or piercing shops were first approached about the
study by a letter, followed by a visit by a PHSA study nurse.
During this visit, both clients and tattoo artists and piercers were
invited to participate. All participants could choose to receive their
HBV and HCV results. In case of positive test results, participants
were notified and referred to their general practitioner for further
diagnostics and referral to a hospital. Participants received 10
euros as an incentive and anti-HBc negatives received a HBV
vaccination series free of cost.
Recruitment during biannual survey at the STI outpatient
clinic. After written informed consent was obtained, the
participants ($17 years) were interviewed about sociodemo-
graphics and risk factors for blood borne diseases and STI and
blood samples were collected. When a subject had two or more
tattoos and/or piercings, additional information on tattoos and
piercings characteristics was gathered, as was done at the tattoo
sites. During this survey, however, testing for HCV and HIV was
performed anonymously and therefore participants were not
notified of the results. STI and anti-HBc status were tested as part
of the routine STI clinic consult and these test results were given to
participants [16]. Anti-HBc data were merged with the survey
data.
Laboratory testing
Participants were tested for the presence of anti-Hbc and anti-
HCV by means of a third-generation commercial microparticle
EIA system (AxSym Core, Abbott, Germany and AxSym HCV
version 3.0; Abbott, respectively). Participants whose tests
confirmed anti-HBc were tested for HBsAg to determine whether
they were a chronic carrier. The HBV DNA of HBsAg-positive
samples was isolated, amplified, and sequenced, using an in-house
PCR as described by van Houdt et al. [17]. Anti-HCV positive
samples were confirmed by Immunoblot (Chiron RIBA HCV 3.0
SIA; Ortho-Clinical Diagnostics) and tested for HCV RNA with
an in-house PCR, as described by van de Laar et al. [18].
The nucleotide sequence data have been deposited in the
GenBank sequence database under accession numbers JN547478–
JN547481.
Variables
Tattoo- and piercing-related variables included the location and
number of tattoos and/or piercings, the percentage of the body
covered with tattoos, age at first tattoo or piercing, having a tattoo
and/or piercing from abroad, as well as information about other
established risk factors for acquiring HBV and HCV, such as
blood transfusion before 1992, IDU, and sexual anamnesis. For
those working as a tattoo or piercing artist, data on the working
methods of the tattoo artist and/or piercer were obtained (e.g.
using sterile packed needles, working outside the Netherlands, first
calendar year of working as an artist, and ever having a needle-
stick accident during tattoo or piercing practices). All countries
with a moderate to high risk of infection (.2%) in the general
population were considered to be HBV or HCV endemic [19,20].
Statistical analysis
First, by means of the chi-squared test for categorical variables
and the Mann–Whitney test for continuous variables, character-
istics of participants who tested positive or negative for anti-HBc
and/or anti-HCV were compared. Categories of the variables
number of tattoos, % body surface tattooed and number of
piercings were defined by cut-off points at the 25
th,5 0
th and 75
th
percentiles for the total group. Confidence intervals (CI) around
prevalence were calculated via the Wilson method, using the
binom statistical package in R [21]. Odds ratios (OR) and 95%
confidence interval in a 262 table with one zero cell count were
calculated via penalized logistic regression using the logistf package
in R [22]. Otherwise, logistic regression in SPSS 17.0 was used.
Multivariate logistic regression models were built using backward
stepwise techniques considering variables with a univariate p-
value#0.25 as potential independent risk factors. A p-value of less
than 0.05 was considered statistically significant. Interaction terms
were checked in the final model but were not significant.
Results
Study population
In total, 434 subjects with multiple tattoos and/or piercings
participated in this study. Sixty-three were included during the
tattoo convention 2007, 59 during the tattoo convention 2008, 60
at tattoo and piercing shops and 252 at the STI clinic in
Amsterdam. Of all the subjects, 187 (43.1%) were male and the
median age was 28 years (IQR 23–37 years) (Table 1). More than
half of the population reported that they had not been vaccinated
against HBV (57.9%). The median number of tattoos and
HBV/HCV and Tattoos/Piercings
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#.
Total
Anti-Hbc
negative
Anti-Hbc
positive Univariate analysis P-value*
Multivariate
analysis P-value*
N=434 (%) N=416 (%) N=18 (%) OR (95% CI)
Social demographics and relevant background information
Median age (IQR)
(per 10 years older)
28 (23–37) 28 (22–36) 32.5 (25–44) 1.65* (1.05–2.59) 0.03 1.68
(1.03–2.75)
0.03
Gender
Female 247 (56.9%) 241 (57.9%) 6 (33.3%) 1 0.05
Male 187 (43.1%) 175 (42.1%) 12 (66.7%) 2.75 (1.01–7.48)
Education
Low 123 (28.5%) 116 (28.0%) 7 (41.2%) 1 0.25
Middle 181 (41.9%) 173 (41.6%) 8 (47.1%) 3.80 (0.77–18.7)
High 128 (29.6%) 126 (30.3%) 2 (11.8%) 2.91 (0.61–13.9)
Missing 2 1 1
Residence
Amsterdam 317 (74.2%) 305 (74.6%) 12 (66.7%) 1 0.46
Other 110 (25.8%) 104 (25.4%) 6 (33.3%) 1.46 (0.54–4.01)
Missing 7 7
Born in HBV endemic country
No 364 (83.9%) 356 (85.6%) 8 (44.4%) 1 ,0.001 1 ,0.001
Yes 70 (16.1%) 60 (14.4%) 10 (55.6%) 7.42 (2.81–19.6) 7.39
(2.77–19.7)
Recruitment site
STI outpatient clinic 252 (58.1%) 241 (57.9%) 11 (61.1%) 1 0.79
Tattoo venue 182 (41.9%) 175 (42.1%) 7 (38.9%) 0.88 (0.33–2.31)
HBV vaccination
(self-reported)
No 249 (57.9%) 237 (57.4%) 12 (70.6%) 1 0.21
Yes 136 (31.6%) 134 (32.4%) 2 (11.8%) 0.30 (0.07–1.34)
Don’t know 45 (10.5%) 42 (10.2%) 3 (17.6%) 1.41 (0.38–5.21)
Missing 4 3 1
HCV status
Negative 433 (99.8%) 415 (99.8%) 18 (100%) 1 0.39
Positive 1 (0.2%) 1 (0.2%) 0 7.49 (0.08–708.7)
Snorting drugs
No 243 (63.1%) 229 (62.2%) 14 (82.4%) 1 0.11
Yes 142 (36.9%) 139 (37.8%) 3 (17.6%) 0.35 (0.10–1.25)
Missing 49 48 1
Tattoo and piercing characteristics
Being a tattoo/piercing artist
No 345 (80.6%) 332 (80.8%) 13 (76.5%) 1 0.66
Yes 83 (19.4%) 79 (19.2%) 4 (23.5%) 1.29 (0.41–4.07)
Missing 6 5 1
Tattoo and piercing
Piercing 59 (13.6%) 58 (13.9%) 1 (5.6%) 1 0.19
Tattoo 114 (26.3%) 106 (25.5%) 8 (44.4%) 4.37 (0.53–35.9)
Tattoo and piercing 261 (60.1%) 252 (60.6%) 9 (50.0%) 2.07 (0.26–16.7)
Number of tattoos
No tattoo 59 (13.6%) 58 (13.9%) 1 (5.6%) 1 0.77
1–2 106 (22.4%) 101 (24.3%) 5 (27.8%) 2.87 (0.32–25.2)
3–4 91 (21.0%) 88 (21.2%) 3 (16.7%) 1.98 (0.20–19.5)
HBV/HCV and Tattoos/Piercings
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median body surface reported by the participants as tattooed was
18% (IQR 9%–27%). Participants included at tattoo venues were
significantly more often men, older, with higher education, and
had a larger number of tattoos and piercings compared to the
participants who were included at the STI clinic.
Hepatitis B
In total 18/434 (4.2%, 95% CI; 2.64–6.46) participants were
found to be anti-HBc positive and were considered as having had a
HBV infection (Table 1). The country of birth of the anti-HBc
positives were; South-Africa, Aruba, Surinam (n=7), Indonesia,
Germany, and the Netherlands (n=7 of whom one had Ghanaian
parents and one had Vietnamese parents). Three of the 18 anti-
HBc-positive participants were chronic carriers (HBsAg positive),
which is 0.7% (3/434, 95% CI: 0.24–2.01) of the total study
population. In univariate analysis, older age, male sex, and born in
an HBV-endemic country were associated with anti-HBc seropos-
itivity (Table 1). None of the tattoo-related variables, including the
number of tattoos and piercings, percentage of the body surface
tattooed, having a tattoo in an HBV-endemic country or being a
tattoo artist, were significantly associated with HBV. In multivariate
analysis, older age and being born in an HBV-endemic country
were independently associated with anti-HBc seropositivity (OR
1.68; 95% CI: 1.03–2.75 per 10 years older and OR 7.39; 95% CI:
2.77–19.7 respectively). Tattoo artists appeared to be more likely to
have been vaccinated against HBV (self-reported) than those who
were not tattoo artists (OR 2.52; 95% CI: 1.49–4.24).
An additional analysis, conducted among tattoo and piercing
artists only, confirmed that none of the tattoo and/or piercing
variables were significantly associated with HBV. Restricting our
analysis to unvaccinated participants, again no tattoo- and/or
piercing-related variables were associated with HBV.
After sequencing the viral HBV DNA of the three chronic
carriers, two proved to be infected with genotype A. One of the
two was German, the other was Surinamese. Neither reported a
high number of lifetime sexual partners, but they did have multiple
tattoos (both N=15). The other chronic carrier was infected with
genotype B and of Indonesian ethnicity, with only a few tattoos
(N=4) and a small number of lifetime sexual partners, and might
have been infected in the country of birth.
Hepatitis C
Only one participant was HCV infected (0.2%, 95% CI: 0.01–
1.29) with genotype 1a. This participant was a tattoo artist who
received a tattoo more than 100 times, and reported several other
potential risk factors for HCV, including needle-stick accidents. In
phylogenetic analysis, this strain did not cluster with MSM-, IDU-
specific or endemic clusters (data not shown).
Discussion
In this study, we did not find any association between tattoo or
piercing characteristics and HBV or HCV infection. The HCV
prevalence in this study was low (0.2%, 95% CI: 0.01–1.29) and
comparable to the prevalence of the general Dutch population (0.1–
0.4%) [23].TheHBsAgprevalenceandanti-HBVprevalenceinthe
Netherlands are estimated to be 0.3–0.5% and 2.1% (95% CI: 1.6–
2.7), respectively [24,25]. In our study, the HBsAg and anti-HBc
prevalences were 0.7% and 4.2%, respectively, which is in line with
the estimates of the Amsterdam population (0.4%, 95% CI: 0.11–
0.72 and 9.9%, 95% CI: 1.0–8.0 respectively) which are somewhat
Total
Anti-Hbc
negative
Anti-Hbc
positive Univariate analysis P-value*
Multivariate
analysis P-value*
N=434 (%) N=416 (%) N=18 (%) OR (95% CI)
5–10 96 (22.1%) 92 (22.1%) 4 (22.2%) 2.52 (0.28–23.1)
.11 82 (18.9%) 77 (18.5%) 5 (27.8%) 3.77 (0.43–33.1)
% body surface tattooed
No tattoo 59 (13.6%) 58 (13.9%) 1 (5.6%) 1 0.61
1%–9% 116 (26.7%) 113 (27.2%) 3 (16.7%) 1.54 (0.16–15.1)
10%–18% 117 (27.0%) 110 (26.4%) 7 (38.9%) 3.69 (0.44–30.7)
19%–31.5% 68 (15.7%) 65 (15.6%) 3 (16.7%) 2.67 (0.27–26.5)
.31.5% 74 (17.0%) 70 (16.8%) 4 (22.2%) 3.31 (0.36–30.5)
Tattoo and/or piercing in HBV
endemic country
Tattoo/piercing in low endemic country 322 (74.2%) 310 (74.5%) 12 (66.7%) 1 0.46
Tattoo/piercing in endemic country 112 (25.8%) 106 (25.5%) 6 (33.3%) 1.46 (0.54–3.99)
Number of piercings
No piercing 114 (26.2%) 106 (25.5%) 8 (44.4%) 1 0.36
1 65 (15.0%) 64 (15.6%) 1(5.6%) 0.21 (0.03–1.69)
2 104 (24.0%) 99 (23.8%) 5 (27.8%) 0.68 (0.21–2.14)
3–4 72 (16.6%) 71 (17.1%) 1(5.6%) 0.19 (0.02–1.53)
$5 79 (18.2%) 76 (18.3%) 3 (16.6%) 0.52 (0.13–2.04)
Univariate and multivariate analysis logistic regression analysis.
#Men who have sex with men (MSM) and injecting drug users (IDU) are excluded;
*overall p- value.
doi:10.1371/journal.pone.0024736.t001
Table 1. Cont.
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Comparing participants having a tattoo and participants not having
a tattoo in a population based survey in Amsterdam [26] we found
no differences in HBV and HCV prevalence between the two
groups (data not shown). The same accounts for the larger popula-
tion of participants in the biannual survey at the STI-outpatient
clinic, which is one of the recruitment sites (data not shown). Based
on thesefindings togetherwith thefact that we didnot found a dose-
response relationship between tattoo characteristics such as the
number of tattoos or piercings and the percentage body surface
tattooed and HBV or HCV infection, we conclude that people with
multiple tattoos and/or piercings are not a risk group for HBV or
HCV in the Netherlands.
HCV is mainly transmitted by blood-blood contact and main risk
factors in high income countries are IDU and receiving blood or
blood products before 1992 [1,27,28]. The transmission route for
HBV are blood-blood contact and sexual contact. The main risk
factors in low endemic counties are unsafe sex, and injecting drug use,
whereas in intermediate and high endemic countries most infections
are acquired perinatally or during early childhood [2]. Since most
anti-HBc positive participants (67%, adult first or second generation)
originated from intermediate or high endemic countries, and born in
an HBV endemic country was significantly associated with HBV, it is
likely that these participants were infected in the country of birth, and
not by sexual transmission in the Netherlands, which was more
expected in attendees of a STI outpatient clinic.
In Amsterdam, for two decades already, guidelines for hygienic
practices have been implemented in tattoo and piercing shops.
Based on the Amsterdam guidelines, the Dutch government
implemented a nationwide law in June 2007 that states that all
tattoo and piercing shops in the Netherlands are obliged to have a
licence, which has to be obtained yearly and has to be permitted by
a local Public Health Service [14,29]. Since most participants
included in this study were living in the region of Amsterdam
(74.2%), it is possible that the transmission of HBV and HCV
originating in tattoo and piercing shops in Amsterdam has been
curtailed by the early implementation of hygienic guidelines. An
alternative explanation is that the probability of introduction of
HBV and HCV in the tattoo population might be very small due to
the low HBV/HCV prevalence in the general Dutch population.
In the Netherlands, having a tattoo or piercing is currently
defined as a risk factor for HBV/HCV and screening for the
presence of both viruses in this group is recommended [30].
However, our findings suggest that for persons having a tattoo or
piercing in a country where guidelines for hygiene practices have
been available for a considerable time period, this screening
should not routinely be advised.
Arcari et al. [4] concluded in their review that in most studies
IDU is a major confounding factor. Most often, when there is an
association found, there is no information available about the
tattoo venue and other tattoo characteristics (e.g. number) in these
studies [4] and therefore residual confounding could play a role.
To our best knowledge, our study is the only study worldwide
exclusively performed in people with multiple tattoos and piercings
who were not IDU or MSM. The fact that we did not find any
association suggests that residual confounding might indeed have
played a role in previous studies. However, our findings do not
apply to populations with a high HBV/HCV prevalence or to
countries without hygiene guidelines.
In conclusion, in low HBV/HCV-endemic countries where strict
hygiene guidelines for tattoo and piercing practices have been
implemented, like in the Netherlands, tattoo and piercing practices
are not associated with HBV/HCV infection and people with
tattoos and/or piercings should not be advised to be screened for
HBV and HCV in order to trace undiagnosed infections. We
recommend low and high endemic countries to implement hygienic
guidelines fortattooand piercing shops,includingpermanentmake-
up salons, to decrease the potential risk of HBV and HCV
transmission. More studies are needed to generalize our findings,
and should be conducted exclusively among people with multiple
tattoos and piercings in both low and high endemic countries that
exclude IDU and MSM but include information on tattoo and
piercing practices, as well as hygiene guidelines.
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